Joel Greenblatt’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.9K Sell
15,921
-2,562
-14% -$6.51K ﹤0.01% 1781
2026
Q1
$36.2K Sell
18,483
-41,219
-69% -$96.7K ﹤0.01% 1744
2025
Q4
$162K Buy
+59,702
New +$196K ﹤0.01% 1669
2025
Q2
Sell
-71,788
Closed -$317K 1690
2025
Q1
$317K Buy
71,788
+54,111
+306% +$254K ﹤0.01% 1348
2024
Q4
$82.2K Buy
17,677
+4,182
+31% +$23K ﹤0.01% 1406
2024
Q3
$93.7K Sell
13,495
-178
-1% -$1.4K ﹤0.01% 1377
2024
Q2
$107K Sell
13,673
-3,477
-20% -$25.8K ﹤0.01% 1376
2024
Q1
$122K Sell
17,150
-1,834
-10% -$12.1K ﹤0.01% 1322
2023
Q4
$127K Sell
18,984
-53,106
-74% -$299K ﹤0.01% 1284
2023
Q3
$406K Buy
72,090
+39,552
+122% +$264K 0.01% 1022
2023
Q2
$180K Buy
32,538
+10,411
+47% +$56K ﹤0.01% 1242
2023
Q1
$138K Sell
22,127
-4,394
-17% -$24.5K ﹤0.01% 1273
2022
Q4
$124K Buy
26,521
+4,050
+18% +$20K ﹤0.01% 1166
2022
Q3
$105K Buy
+22,471
New +$142K ﹤0.01% 1125

Other funds holding GDRX

Joel Greenblatt's GDRX Position: Q2 2026 in Review

Joel Greenblatt reduced its GoodRx Holdings (GDRX) stake by 14% in Q2 2026, selling an estimated $6.51K and leaving 15,921 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Joel Greenblatt first reported a position in GDRX in Q3 2022 and has held it in 14 quarters since. The position peaked at $406K in Q3 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Joel Greenblatt held 15,921 shares of GoodRx Holdings worth $45.9K as of Q2 2026.
  • Joel Greenblatt sold 2,562 GoodRx Holdings shares in Q2 2026, an estimated $6.51K.
  • GoodRx Holdings made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1781 holding.
  • Joel Greenblatt first reported a position in GoodRx Holdings in Q3 2022 and has held it in 14 quarters since.
  • Joel Greenblatt's GoodRx Holdings position peaked at $406K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.